Contact Us
About Us
Subscribe
My Portfolio
My Account
Contact Us
About Us
Subscribe
My Account
My Portfolio

Insider Transactions by Valentine Karen

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksJan 19, 2021Sale$22.7434,406782,29717,203Jan 20, 2021, 05:56 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksMay 05, 2020Sale$25.769,488244,3734,744May 07, 2020, 04:34 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksMay 06, 2020Option Exercise$25.5325,132641,64612,566May 07, 2020, 04:34 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksApr 27, 2020Sale$25.8280020,652400Apr 29, 2020, 08:03 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksApr 20, 2020Sale$22.581,57835,624789Apr 22, 2020, 08:17 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksApr 17, 2020Option Exercise$23.354,600107,3892,300Apr 20, 2020, 05:52 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksApr 16, 2020Sale$22.535,996135,1142,998Apr 20, 2020, 05:52 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksApr 09, 2020Sale$21.891,27027,799635Apr 13, 2020, 04:56 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksMar 09, 2020Sale$20.401,23425,168617Mar 11, 2020, 04:11 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 12, 2020Option Exercise$23.263,00069,7771,500Feb 14, 2020, 05:09 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 13, 2020Sale$22.708,946203,0764,473Feb 14, 2020, 05:09 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 10, 2020Option Exercise$22.3328,192629,39214,096Feb 13, 2020, 06:22 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 11, 2020Option Exercise$23.2617,100397,8318,550Feb 13, 2020, 06:22 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 10, 2020Sale$22.5028,192634,46114,096Feb 12, 2020, 05:36 PM
CNSTCONSTELLATION PHARMACEUTICALS INCValentine KarenSee RemarksFeb 11, 2020Sale$23.2617,100397,8318,550Feb 12, 2020, 05:36 PM
AGENAGENUS INCValentine KarenChief Legal OfficerOct 09, 2017Option Exercise$3.5924,82489,118109,879Dec 14, 2017, 04:14 PM
AGENAGENUS INCValentine KarenChief Legal OfficerDec 12, 2017Sale$3.468,35828,921101,521Dec 14, 2017, 04:14 PM
AGENAGENUS INCValentine KarenChief Legal OfficerApr 19, 2017Option Exercise$3.3932,877111,45393,110Apr 21, 2017, 04:13 PM
AGENAGENUS INCValentine KarenChief Legal OfficerApr 26, 2016Option Exercise$4.1532,890136,49476,356May 13, 2016, 05:53 PM
AGENAGENUS INCValentine KarenChief Legal OfficerApr 26, 2016Option Exercise$4.1532,890136,49476,356May 13, 2016, 05:26 PM
AGENAGENUS INCValentine KarenChief Legal OfficerApr 26, 2016Option Exercise$4.1532,561135,12824,574Apr 28, 2016, 04:07 PM
AGENAGENUS INCValentine KarenVP General CounselJan 23, 2014Sale$3.502,8509,97551,534Jan 24, 2014, 05:13 PM
AGENAGENUS INCValentine KarenVP, General CounselJan 28, 2013Option Exercise$4.354171,81429,384Jan 29, 2013, 10:22 AM
AGENAGENUS INCValentine KarenVP General CounselOct 26, 2012Option Exercise$4.424171,84328,967Oct 29, 2012, 04:36 PM
AGENAGENUS INCValentine KarenVP, General CounselJul 26, 2012Option Exercise$4.614161,91826,140Jul 30, 2012, 02:10 PM
AGENAGENUS INCValentine KarenVP, General CounselJun 20, 2012Option Exercise$4.921,5647,69528,623Jun 21, 2012, 04:55 PM
AGENAGENUS INCValentine KarenVP, General CounselJun 21, 2012Option Exercise$5.052,89914,64025,724Jun 21, 2012, 04:55 PM
AGENAGENUS INCValentine KarenVP, General CounselJun 19, 2012Option Exercise$5.2610,05052,86330,187Jun 21, 2012, 04:55 PM
AGENAGENUS INCValentine KarenVP General CounselApr 26, 2012Option Exercise$6.434172,68120,137Apr 30, 2012, 02:04 PM
AGENAGENUS INCValentine KarenVP, General CounselMar 15, 2012Option Exercise$5.312,90415,42019,720Mar 16, 2012, 02:24 PM
AGENAGENUS INCValentine KarenVP, General CounselJan 26, 2012Option Exercise$2.764171,15116,816Jan 31, 2012, 08:48 AM
AGENAGENUS INCValentine KarenVP, General CounselJan 03, 2012Option Exercise$2.1715,20833,00116,399Jan 05, 2012, 02:55 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 29, 2011Sale$1.987,60515,0581,191Dec 29, 2011, 04:19 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 27, 2011Sale$2.142,1694,64210,097Dec 29, 2011, 04:19 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 28, 2011Sale$2.091,3012,7198,796Dec 29, 2011, 04:19 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 21, 2011Sale$2.242,3485,25514,051Dec 23, 2011, 05:15 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 22, 2011Sale$2.191,1772,57812,874Dec 23, 2011, 05:15 PM
AGENAGENUS INCValentine KarenVP, General CounselDec 23, 2011Sale$2.206081,33612,266Dec 23, 2011, 05:15 PM
AGENAGENUS INCValentine KarenVP, General CounselOct 26, 2011Option Exercise$2.704161,12316,399Oct 28, 2011, 11:01 AM
AGENAGENUS INCValentine KarenVP, General CounselSep 12, 2011Option Exercise$0.553,3341,83495,902Sep 13, 2011, 12:55 PM
AGENAGENUS INCValentine KarenVP General CounselJul 26, 2011Option Exercise$0.792,5001,97592,568Jul 28, 2011, 11:48 AM
AGENAGENUS INCValentine KarenVP, General CounselApr 26, 2011Option Exercise$0.922,5002,30090,068Apr 28, 2011, 12:19 PM
AGENAGENUS INCValentine KarenVP and General CounselMar 09, 2011Option Exercise$0.988,7128,53887,568Mar 11, 2011, 09:56 AM
AGENAGENUS INCValentine KarenVP and General CounselJan 26, 2011Option Exercise$0.952,5002,37578,856Jan 28, 2011, 10:26 AM
AGENAGENUS INCValentine KarenVp and General CounselJan 20, 2011Option Exercise$0.9419,86518,67376,356Jan 20, 2011, 05:02 PM
AGENANTIGENICS INC /DE/Valentine KarenVP and General CounselOct 26, 2010Option Exercise$0.982,5002,45058,991Oct 28, 2010, 02:58 PM
AGENANTIGENICS INC /DE/Valentine KarenVP and General CounselOct 27, 2010Sale$0.982,5002,45056,491Oct 28, 2010, 02:58 PM
AGENANTIGENICS INC /DE/Valentine KarenVP and General CounselSep 10, 2010Option Exercise$0.933,3333,10059,824Sep 14, 2010, 02:30 PM
AGENANTIGENICS INC /DE/Valentine KarenVP and General CounselSep 14, 2010Sale$0.913,3333,04656,491Sep 14, 2010, 02:30 PM

Looking for more premium content?

We have created a comprehensive group of tools that allows you to estimate the intrinsic value of investments.

Subscribe